Yu‐Sun Chang

Shenyang Ligong University — China

Medicine · Health Sciences

62h-index12.7kcitations357works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral-associated cancers and disorders(71), RNA modifications and cancer(64), Lymphoma Diagnosis and Treatment(29), Cancer-related molecular mechanisms research(27), Cancer-related gene regulation(27)

Publications356 total

The impact of primary tumor location of colorectal cancer on the survival outcome of patients with brain metastasis: a systematic review and meta-analysis
European journal of medical research·2025Open Access
Glucagon-Like Peptide 1 Receptor Agonist Use and Vertebral Fracture Risk in Type 2 Diabetes
JAMA Surgery·2025Open Access
Development of Visual Detection of African Swine Fever Virus Using CRISPR/AapCas12b Lateral Flow Strip Based on Viral Major Capsid Protein Gene B646L
Animals·2025Open Access
Abstract 4357689: Upfront Combination of High-Intensity Statin and Ezetimibe Reduces Major Adverse Cardiovascular Events in Acute Myocardial Infarction: A Target-Trial Emulation
Circulation·2025
Development of Visual Detection of African Swine Fever Virus Using CRISPR/AapCas12b Lateral Flow Strip Based on Viral Major Capsid Protein Gene B646L
Preprints.org·2025Open Access
CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical models
Journal of Clinical Investigation·2025· 6 citedOpen Access
Application Advances of Lentiviral Vectors: From Gene Therapy to Vaccine Development
Molecular Biotechnology·2025· 1 cited
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma
Proceedings of the National Academy of Sciences·2025· 5 citedOpen Access
Glucagon-like peptide-1 receptor agonists and the risk of chemotherapy-induced peripheral neuropathy in patients with diabetes: A real-world study.
Journal of Clinical Oncology·2025
Can we determine the mechanism behind cancer risk reduction with glucagon-like peptide-1 receptor agonists (GLP-1RAs)?
Journal of Clinical Oncology·2025· 1 cited
Racial differences in serious immune-related adverse events among cancer patients receiving immune checkpoint inhibitors.
Journal of Clinical Oncology·2025
Research on Robot Path Planning Based on Deep Reinforcement Learning with Big Data
2025
4444 Delineation of Supraclavicular Lymph Node Levels in Abdominopelvic Tumors: Insights from the ‘Block- Reflux’ Lymphatic Pathway—A Retrospective Study
Radiotherapy and Oncology·2025
Abstract LB389: R-loop formation triggers STING-mediated anti-tumor immunity following inactivation of a cyclin-dependent kinase
Cancer Research·2025
Integrated duplex reverse transcription-recombinase aided amplification (RT-RAA) and lateral flow assay (LFA) for rapid simultaneous detection of Zika virus and Japanese encephalitis virus in single reaction format
Talanta·2025
Validating Khorana Risk Score in gastric cancer patients on immune checkpoint inhibitors and chemotherapy
Immunotherapy·2025· 2 cited
Allogeneic versus autologous hematopoietic stem cell transplantation for adult T-lymphoblastic lymphoma: A real-world multicenter analysis in China
Cancer Letters·2025· 8 cited
Comparative survival outcome of synchronous and metachronous brain metastasis from colorectal cancer: A meta‑analysis
Oncology Letters·2025· 2 citedOpen Access
Discovery of <b>YJZ5118</b>: A Potent and Highly Selective Irreversible CDK12/13 Inhibitor with Synergistic Effects in Combination with Akt Inhibition
Journal of Medicinal Chemistry·2025· 4 citedOpen Access
P246 – Dapagliflozin inhibits kidney stones via modulating autophagy
European Urology·2025
page 1 of 18Next →

Frequent Co-authors

Jau‐Song Yu(18), Chih‐Ching Wu(14), Kai‐Ping Chang(13), Chuen Hsueh(11), Ying Liang(8), Chia‐Wei Hsu(7), Chia‐Jung Yu(7), Kun‐Yi Chien(6), Yi‐Ting Chen(6), Chien‐Lun Chen(4), Hsiao‐Wei Chen(4), Ting Chung(4), Hao‐Ping Liu(4), Hua‐Chien Chen(4), Lih‐Chyang Chen(4), David M. Ojcius(4), Chi‐Sheng Wu(4), Chia‐Chun Chen(4), Hsin-Pai Li(3), Xirui He(3)